Literature DB >> 33536379

Predictors of SARS-CoV-2 Positivity Based on RT-PCR Swab Tests at a Drive-Through Outpatient Clinic for COVID-19 Screening in Japan.

Tadashi Ishii1, Shigeki Kushimoto2, Yukio Katori3, Shigeo Kure4, Kaoru Igarashi5, Motoo Fujita6, Shin Takayama1, Michiaki Abe1, Junichi Tanaka1, Akiko Kikuchi1, Yoshiko Abe1, Hiroyuki Imai7, Yohei Inaba8, Yoko Iwamatsu-Kobayashi9, Takashi Nishioka10, Ko Onodera11, Tetsuya Akaishi1.   

Abstract

In response to the COVID-19 pandemic caused by SARS-CoV-2 in 2020, we conducted drive-through nasopharyngeal swab testing for COVID-19 in Sendai city, Japan, since April 2020. All tested individuals were judged in advance by public health centers for the necessity of undergoing the test with possible contact history and/or symptoms suggestive of COVID-19. In this study, to identify the predictors of SARS-CoV-2 test positivity for more efficient and evidenced selection of suspected individuals, we enrolled 3,540 consecutive individuals, tested in the first 7 months of the testing program, with data regarding to the history of close contact with COVID-19 patients, including those involved in cluster outbreaks. This cohort included 284 foreign students (257 males and 27 females) from a vocational school involved in the largest cluster outbreak in the area. Close contact history was present in 952 (26.9%) of the participants. The reverse transcription-polymerase chain reaction (RT-PCR) test results showed that 164 participants (4.6%) were positive and 3,376 participants (95.4%) were negative for the SARS-CoV-2 nucleocapsid gene (N2). In the univariate and multivariate analyses, history of close contact with COVID-19 patients, higher age, cough symptoms, and non-native ethnicity were predictors for SARS-CoV-2 test positivity. However, the significance of age and foreign nationality disappeared or declined upon excluding the foreign students from the aforementioned largest cluster outbreak. In conclusion, a history of close contact with COVID-19 patients and the presence of cough symptoms are significant predictors of SARS-CoV-2 test positivity.

Entities:  

Keywords:  SARS-CoV-2; coronavirus disease 2019 (COVID-19); drive-through; nasopharyngeal swab test; reverse transcription polymerase chain reaction (RT-PCR)

Mesh:

Year:  2021        PMID: 33536379     DOI: 10.1620/tjem.253.101

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN: 0040-8727            Impact factor:   1.848


  5 in total

Review 1.  Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.

Authors:  Thomas Struyf; Jonathan J Deeks; Jacqueline Dinnes; Yemisi Takwoingi; Clare Davenport; Mariska Mg Leeflang; René Spijker; Lotty Hooft; Devy Emperador; Julie Domen; Anouk Tans; Stéphanie Janssens; Dakshitha Wickramasinghe; Viktor Lannoy; Sebastiaan R A Horn; Ann Van den Bruel
Journal:  Cochrane Database Syst Rev       Date:  2022-05-20

2.  Coronavirus disease 2019 transmission and symptoms in young children during the severe acute respiratory syndrome coronavirus 2 Delta variant and Omicron variant outbreaks.

Authors:  Tetsuya Akaishi; Tadashi Ishii
Journal:  J Int Med Res       Date:  2022-05       Impact factor: 1.573

3.  COVID-19 Screening for Hospitalized Patients: The Role of Expanded Hospital Surveillance in a Low Prevalence Setting.

Authors:  Jen-Yu Hsu; Po-Yu Liu; Chien-Hao Tseng; Chia-Wei Liu; Wan-Ting Yang; Wei-Hsuan Huang; Shu-Yuan Li; Ya-Chun Liao; Ming-Ju Wu
Journal:  J Multidiscip Healthc       Date:  2021-10-27

4.  Effectiveness of third vaccine dose for coronavirus disease 2019 during the Omicron variant pandemic: a prospective observational study in Japan.

Authors:  Tetsuya Akaishi; Shigeki Kushimoto; Yukio Katori; Noriko Sugawara; Hiroshi Egusa; Kaoru Igarashi; Motoo Fujita; Shigeo Kure; Shin Takayama; Michiaki Abe; Akiko Kikuchi; Minoru Ohsawa; Kota Ishizawa; Yoshiko Abe; Hiroyuki Imai; Yohei Inaba; Yoko Iwamatsu-Kobayashi; Takashi Nishioka; Ko Onodera; Tadashi Ishii
Journal:  Sci Rep       Date:  2022-08-10       Impact factor: 4.996

5.  COVID-19 transmission in group living environments and households.

Authors:  Tetsuya Akaishi; Shigeki Kushimoto; Yukio Katori; Shigeo Kure; Kaoru Igarashi; Shin Takayama; Michiaki Abe; Junichi Tanaka; Akiko Kikuchi; Ko Onodera; Tadashi Ishii
Journal:  Sci Rep       Date:  2021-06-02       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.